Horrell Capital Management’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History
Bought
Maintained
Sold
Other funds holding EPRS
Horrell Capital Management's EPRS Position: Q3 2016 in Review
Horrell Capital Management sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 1,500 shares — an estimated $1K sold.
Horrell Capital Management first reported a position in EPRS in Q2 2016 and held it in 1 quarter. The position peaked at $1K in Q2 2016. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.
- Horrell Capital Management reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
- Horrell Capital Management sold 1,500 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $1K.
- Horrell Capital Management first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q2 2016 and held it in 1 quarter.
- Horrell Capital Management's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $1K in Q2 2016.
- 3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.
Based on Horrell Capital Management's 13F filing for Q3 2016, filed 20 Oct 2016.